Cargando…
Dysferlin Mediates the Cytoprotective Effects of TRAF2 Following Myocardial Ischemia Reperfusion Injury
BACKGROUND: We have demonstrated that tumor necrosis factor (TNF) receptor‐associated factor 2 (TRAF2), a scaffolding protein common to TNF receptors 1 and 2, confers cytoprotection in the heart. However, the mechanisms for the cytoprotective effects of TRAF2 are not known. METHODS/RESULTS: Mice wit...
Autores principales: | Tzeng, Huei‐Ping, Evans, Sarah, Gao, Feng, Chambers, Kari, Topkara, Veli K., Sivasubramanian, Natarajan, Barger, Philip M., Mann, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959693/ https://www.ncbi.nlm.nih.gov/pubmed/24572254 http://dx.doi.org/10.1161/JAHA.113.000662 |
Ejemplares similares
-
Ischemia reperfusion injury provokes adverse left ventricular remodeling in dysferlin-deficient hearts through a pathway that involves TIRAP dependent signaling
por: Evans, Sarah, et al.
Publicado: (2020) -
Roles of TRAFs in Ischemia-Reperfusion Injury
por: Zhou, Wei, et al.
Publicado: (2020) -
Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury
por: Hatcher, Heather C., et al.
Publicado: (2015) -
Cytoprotection of rat hepatocytes by desipramine in a model of simulated ischemia/reperfusion
por: Shin, Jun-Kyu, et al.
Publicado: (2021) -
TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1–JNK/p38 Signaling
por: Xu, Weipan, et al.
Publicado: (2019)